176 The Cost-Effectiveness of Dapagliflozin for Chronic Heart Failure in Australia

https://hdl.handle.net/10779/DRO/DU:26377585

journal contribution

posted on 2024-07-26, 02:27 authored by Feby SaviraFeby Savira, B Wang, A Kompa, Z Ademi, A Owen, S Zoungas, A Tonkin, D Liew, E Zomer

176 The Cost-Effectiveness of Dapagliflozin for Chronic Heart Failure in Australia

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1016/j.hlc.2020.09.183

Language

eng

Publication classification

E3.1 Extract of paper

Journal

Heart, Lung and Circulation

Volume

29

Pagination

S114-S114

ISSN

1443-9506

Publisher

Elsevier BV

Publication URL

http://dx.doi.org/10.1016/j.hlc.2020.09.183

Usage metrics

Categories

Keywords

Uncategorised value

Licence

All Rights Reserved

Exports